|
Session 25
Oral Abstracts
OIs, AIDS-Defining Conditions, and HIV-1 Disease Burden
Tuesday, 10 - 11:45 am
Room: Petree Hall |
| 10:00 am 80 |
Clinical Endpoints for Randomized Clinical Trials: All AIDS-defining Conditions Are Not Created Equal
Amanda Mocroft and Antiretroviral Therapy Cohort Collaboration
Royal Free and Univ Coll London Med Sch, UK |
| 10:15 am 81 |
Early Mortality among Patients with HIV-associated TB in Africa: Implications for the Time to Initiate ART
Stephen Lawn*1,2, Stephen Lawn*1,2, L Myer3,4, L Myer3,4, L G Bekker1, and R Wood1
1Desmond Tutu HIV Ctr, Faculty of Hlth Sci, Univ of Cape Town, South Africa; 2London Sch of Hygiene and Tropical Med, UK; 3Sch of Publ Hlth and Family Med, Faculty of Hlth Sci, Univ of Cape Town, South Africa; and 4Columbia Univ Mailman Sch of Publ Hlth, New York, NY, US |
| 10:30 am 82 |
Causes of Death in HIV-infected Adults with TB Admitted to 2 Hospitals in Soweto, South Africa
Neil Martinson*1,2, Neil Martinson*1,2, M Hale2,3, M Hale2,3, A Karstaedt2,4, A Karstaedt2,4, F Venter2, P King2,3, P King2,3, E Marais2,3, E Marais2,3, and R Chaisson1
1Johns Hopkins Univ Ctr for TB Res, Baltimore, MD, US; 2Univ of the Witwatersrand, Johannesburg, South Africa; 3Natl Hlth Lab Svc, Johannesburg, South Africa; and 4Chris Hani Baragwanath Hosp, Soweto, South Africa |
| 10:45 am 83 |
Cotrimoxazole Prophylaxis Reduced the Early Mortality of HIV-infected Patients on ART in Malawi
David Lowrance*1, S Makombe2, A Harries2,3,4, A Harries2,3,4, A Harries2,3,4, J Yu5, J Aberle-Grasse6, O Eiger6, R Shiraishi1, B Marston1, T Ellerbrock1, and E Libamba2
1Global AIDS Prgm, CDC, Atlanta, GA, US; 2Ministry of Hlth, Lilongwe, Malawi; 3Family Hlth Intl, Arlington, VA, US; 4London Sch of Hygiene and Tropical Med, UK; 5Taiwan Med Mission, Mzuzu Central Hosp, Malawi; and 6Global AIDS Prgm, CDC Malawi, Lilongwe |
| 11:00 am 84 |
HIV-induced Immunodeficiency and Risk of Fatal AIDS-defining and Non-AIDS-defining Malignancies: Results from the D:A:D Study
Antonella D'Arminio Monforte*1, D Abrams2, C Pradier3, R Weber4, F Bonnet5, S De Wit6, N Friis-Møller7, A Phillips8, C Sabin8, J Lundgren7, and The D:A:D Study Group
1ICONA, Hosp San Paolo, Univ of Milan, Italy; 2Cancer Res Inst, Univ of California, San Francisco, US; 3Nice Cohort, Ctr Hosp Univ Nice, Hosp de l'Archet, France; 4Swiss HIV Corhort Study, Univ Hosp Zuric; 5INSERM E0338 & U593, ISPED, Univ Victor Segalen Bordeaux 2, France; 6Ctr Hosp Univ St Pierre, Brussels, Belgium; 7Copenhagen HIV Prgm, Hvidovre Univ Hosp, Denmark; and 8Royal Free Ctr for HIV Med, Royal Free and Univ Coll London, UK |
| 11:15 am 85 |
The Estimated Burden of HIV Disease in Uganda, 2005-2010
Wolfgang Hladik*1, J Musinguzi2, W Kirungi2, A Opio2, J Stover3, F Kaharuza1, R Bunnell1, J Kafuko4, and J Mermin1
1CDC Uganda, Entebbe; 2Ministry of Hlth, Kampala, Uganda; 3Constella Futures, Washington, DC, US; and 4US Agency for Intl Devt, Kampala, Uganda |
| 11:30 am 86 |
HIV Testing for Family Members of Hospitalized Patients in Uganda
Happy Walusaga*1, R Wanyenze1, C Nawavvu1, B mayanja1, J Ssenkusu1, J Ssempiira1, A Namale2, and M Kamya1
1Mulago-Mbarara Teaching Hosp Joint AIDS Pgm, Uganda and 2CDC Uganda |
|
